Status:
COMPLETED
Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients
Lead Sponsor:
Kansas City Heart Rhythm Research Foundation
Conditions:
Coronavirus Infections
Eligibility:
All Genders
18+ years
Brief Summary
Although arrhythmias appear to be common in COVID-19 patients, arrhythmia mechanisms and characteristics, predisposing factors, incidence of sudden cardiac death and predictors, therapeutic strategies...
Detailed Description
The novel coronavirus (SARS-CoV-2) and the resulting respiratory tract infection (Coronavirus Disease 2019 or COVID-19) is a pandemic with over 3 million cases globally and resulting in \>230,000 deat...
Eligibility Criteria
Inclusion
- Patients \> 18 years of age
- Hospital admission with COVID-19
Exclusion
- ● Age \< 18 years
Key Trial Info
Start Date :
July 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 24 2021
Estimated Enrollment :
666 Patients enrolled
Trial Details
Trial ID
NCT04465552
Start Date
July 10 2020
End Date
January 24 2021
Last Update
September 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kansas City Heart Rhythm Institute
Overland Park, Kansas, United States, 66211